Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 0.14%717 | -4.52%2.98K | -3.46%753 | -3.21%754 | -3.33%754 | -8.09%716 | -20.46%3.12K | -20.41%780 | -20.51%779 | -20.41%780 |
| Gross profit | -0.14%-717 | 4.52%-2.98K | 3.46%-753 | 3.21%-754 | 3.33%-754 | 8.09%-716 | 20.46%-3.12K | 20.41%-780 | 20.51%-779 | 20.41%-780 |
| Operating expense | 175.84%931.5K | 34.74%1.71M | 249.16%673.73K | -9.02%333.77K | 5.36%365.45K | -8.11%337.69K | -77.60%1.27M | -59.14%192.96K | 10.97%366.85K | -88.37%346.87K |
| Selling and administrative expenses | 78.05%187.86K | 63.28%376.94K | 2,942.01%90.07K | 50.10%83.4K | -11.40%97.95K | 70.80%105.51K | -59.42%230.85K | -97.18%2.96K | -51.40%55.57K | -38.29%110.55K |
| -General and administrative expense | 78.05%187.86K | 63.28%376.94K | 2,942.01%90.07K | 50.10%83.4K | -11.40%97.95K | 70.80%105.51K | -59.42%230.85K | -97.18%2.96K | -51.40%55.57K | -38.29%110.55K |
| Other operating expenses | 220.28%743.64K | 28.40%1.33M | 207.19%583.65K | -19.57%250.36K | 13.20%267.5K | -24.06%232.18K | -79.62%1.04M | -48.28%190K | 43.95%311.29K | -91.57%236.32K |
| Operating profit | -175.47%-932.22K | -34.65%-1.71M | -248.14%-674.48K | 9.01%-334.52K | -5.34%-366.21K | 8.11%-338.41K | 77.56%-1.27M | 59.05%-193.74K | -10.88%-367.63K | 88.35%-347.65K |
| Net non-operating interest income (expenses) | -313.55%-13.02K | 293.96%82.16K | 1,780.52%73.94K | -80.14%368 | -86.96%1.76K | 283.40%6.1K | 60.00%20.86K | -4.52%3.93K | 110.39%1.85K | -35.43%13.48K |
| Non-operating interest income | -88.38%779 | 302.57%93.3K | 1,631.64%83.19K | -61.41%1.08K | -83.04%2.33K | 265.49%6.7K | -50.93%23.18K | -10.74%4.8K | -80.02%2.81K | -36.65%13.73K |
| Non-operating interest expense | 2,172.98%13.8K | 379.97%11.14K | 960.32%9.25K | -25.10%716 | 129.32%571 | 148.77%607 | -93.21%2.32K | -31.01%872 | -97.00%956 | -68.72%249 |
| Other net income (expenses) | -91.20%647 | 34.03%-17.32K | 6.52%-13.28K | -380.87%-25.15K | 427.64%13.76K | 143.75%7.35K | -136.47%-26.25K | -395.36%-14.2K | 358.79%8.95K | -107.37%-4.2K |
| Gain on sale of security | -91.20%647 | 142.05%11.04K | -99.67%-13.28K | 129.00%3.21K | 427.64%13.76K | 143.75%7.35K | -97.37%-26.25K | -238.28%-6.65K | 140.46%1.4K | -218.28%-4.2K |
| Special income (charges) | ---- | ---28.36K | --0 | ---28.36K | ---- | ---- | --0 | --0 | --0 | ---- |
| -Less:Write off | ---- | --28.36K | --0 | --28.36K | ---- | ---- | --0 | --0 | --0 | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --7.55K | ---- |
| Income before tax | -190.68%-944.59K | -29.00%-1.65M | -200.87%-613.82K | -0.69%-359.3K | -3.64%-350.69K | 15.26%-324.96K | 77.12%-1.28M | 56.05%-204.01K | -1.13%-356.82K | 88.36%-338.37K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -190.68%-944.59K | -29.00%-1.65M | -200.87%-613.82K | -0.69%-359.3K | -3.64%-350.69K | 15.26%-324.96K | 77.12%-1.28M | 56.05%-204.01K | -1.13%-356.82K | 88.36%-338.37K |
| Net income continuous operations | -190.68%-944.59K | -29.00%-1.65M | -200.87%-613.82K | -0.69%-359.3K | -3.64%-350.69K | 15.26%-324.96K | 77.12%-1.28M | 56.05%-204.01K | -1.13%-356.82K | 88.36%-338.37K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -190.68%-944.59K | -29.00%-1.65M | -200.87%-613.82K | -0.69%-359.3K | -3.64%-350.69K | 15.26%-324.96K | 77.12%-1.28M | 56.05%-204.01K | -1.13%-356.82K | 88.36%-338.37K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -190.68%-944.59K | -29.00%-1.65M | -200.87%-613.82K | -0.69%-359.3K | -3.64%-350.69K | 15.26%-324.96K | 77.12%-1.28M | 56.05%-204.01K | -1.13%-356.82K | 88.36%-338.37K |
| Diluted earnings per share | -0.01 | 0.00%-0.01 | 0 | 0 | 0 | 0 | 80.00%-0.01 | 0 | 0 | 0 |
| Basic earnings per share | -0.01 | 0.00%-0.01 | 0 | 0 | 0 | 0 | 80.00%-0.01 | 0 | 0 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.